spacer
home > > spring 2002 > industry-specific supply chain software - the sugar that helps the medicine go down
PUBLICATIONS


Industry-Specific Supply Chain Software - The Sugar that Helps the Medicine Go Down

Matters such as meeting institutional requirements,item restrictions, traceability, speed and accuracy, storage, despatch, customer service, are very specific needs for the pharmaceutical industry, and the number one deliverables for any pharmaceutical company looking for software. For pharmaceutical distribution there is the added challenge of incredibly large transactions volumes coupled with demanding time constraints.
Pharmaceutical distribution is among the most advanced areas within distribution and supply chain management. It is only recently that integrated software covering the full spectrum of the pharmaceutical industry's sophisticated requirements has reached the market.

Speed and Security are of the Essence

The processing time for the distribution of pharmaceuticals is very short, a dominant feature being fast order cycles. Leading Swiss pharmaceuticals distributor Galexis, for example, accomplishes delivery to a multitude of recipients, with no more than three hours passing between the order being sent electronically by the customer, to delivery at their doorstep.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Andre Grigjanis, Managing Director, Global Competence Centre for IBS Pharma, and John O'Connor, Vice President Global Sales, the IBS Group

Andre Grigjanis is the driving force behind the IBS Group's vertical industry software product, IBS Pharma. During his 10 years as Managing Director of the German subsidiary of IBS (International Business Systems), he has built upon the company's focus on pharmaceutical distribution.

John O'Connor is Vice President Global Sales of the IBS Group, and Area Manager for IBS' operations in Germany and Switzerland. Before joining IBS Group management, he was Managing Director of IBS UK.

spacer
Andre Grigjanis
spacer
spacer
spacer
John O'Connor
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

ERT Continues to Drive Innovation in Virtualization for Respiratory Clinical Trials

ERT, the global leader in clinical endpoints data collection, today announced a strategic partnership with Inofab Health, a healthcare technology company designing and developing ultrasonic spirometry technology for in-clinic and at-home use.
More info >>

White Papers

Driving ROI: The Case for Investing in Contract & Site Regulatory Document Management Services

DrugDev

With tight timelines and complicated regulatory documentation requirements, getting a clinical trial up and running quickly is easier said than done. Key milestones can be achieved only after the successful negotiation of clinical trial agreements and completion of essential regulatory documents. Many clinical trials are hindered by inefficient, labor-intensive processes. Prolonged, inefficient activation can hamper investigator satisfaction and, ultimately, have a negative bottom-line impact for sponsors and CROs. In addition, the Sunshine Act is heightening the importance of financial disclosure in clinical trials. Without a robust financial disclosure strategy, sponsors cannot ensure that physician self-reported financial disclosure data are aligned with the payment data being reported through the Sunshine Act, increasing financial and regulatory risk.
More info >>

 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement